Allergic rhinitis associated with increased risk of nasopharyngeal cancer
the ONA take:
According to a new study published in the journal Head & Neck, researchers in Taiwan have found that patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
For the study, researchers from the National Defense Medical Center in Taipei, Taiwan, analyzed data from 67,532 patients with allergic rhinitis and 135,054 age- and sex-matched controls from the Taiwan Longitudinal Health Insurance Database.
Results showed that patients with allergic rhinitis had a 2.33-fold increased risk of developing nasopharyngeal carcinoma compared to their matched controls.
In addition, researchers found that patients who had four or more visits to their healthcare provider for allergic rhinitis had a significantly increased risk of developing nasopharyngeal carcinoma.
The authors note that the underlying mechanism for the association is unknown, but hypothesize that a malignant change may occur due to chronic repeated airway stimulation and inflammation, epithelial cell changes, and reduced mucociliary clearance.
The American Cancer Society estimates that there will be approximately 3,200 new cases of nasopharyngeal carcinoma in the United States in 2015. Despite being fairly rare in the United States, nasopharyngeal carcinoma is more more common in certain parts of Asia and North Africa, and among recent Chinese and Hmong immigrants in the United States.
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- LIVESTRONG Exercise Program Improves QoL in Cancer Survivors
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|